Article Sidebar
Date Published:
11/07/2022
Online Published:
11/07/2022
Abstract Views: 60
Views PDF: 162
Views PDF: 162
Issue
Section
Scientific research
How to Cite
Do, V. A., & Nguyen, D. H. (2022). BÁO CÁO TRƯỜNG HỢP CA LÂM SÀNG U LYMPHO NGUYÊN PHÁT TẠI MÀNG NÃO. Vietnamese Journal of Radiology and Nuclear Medicine, 21, 64-67. https://doi.org/10.55046/vjrnm.21.400.2015
BÁO CÁO TRƯỜNG HỢP CA LÂM SÀNG U LYMPHO NGUYÊN PHÁT TẠI MÀNG NÃO
Main Article Content
Abstract
SUMMARY
Diffuse large B-cell lymphoma (DLBCL) presented as a primary dural lesion is an extremely rare, which may be misdiagnosed as meningioma. We report the case of DLBCL presented as primary dural lesion. A 42 – year
–old man with headache, MRI of brain showed a lesion occipital region, tracking the dural matter. The patient was treated with tumor resection and the diagnosis of DLBCL was established. Thus, intracranial dural DLBCL must be considered in differential diagnosis of meningeal lesions.
Article Details
Keywords
Primary dural lymphoma, Diffuse large B-cell lymphoma
References
TÀI LIỆU THAM KHẢO
1. I.S. Haldorsen, A. Espeland, E. M. Larsson, Central Nervous System Lymphoma: Characteristic Findings on Traditional and Advanced Imaging, Amerian Joural Neuroadiol 32:984 – 92, 2011.
2. Thomas P. Naidich, Mauricio Castillo, Soonmee Cha, James G. Smirnitopoulos, Imaging of the Brain (2013), Meningeal Neoplasms, p691 -727
3. Iwamoto FM, Abrey LE, Primary dural lymphomas: a review. Neurosurg Focus 2006, 21: E5 – 9.
4. Mneimneh WS, Ashraf MA, Li L, El – Kadi O, Qian J, Nazeer T, Hayner – Buchan A, Primary dural lymphoma: a novel concept of heterogeneous disease. Pathol Int 2013, 63: 68 -72.
5. GalarzaM, Gazzeri R, Elfeky HA, Johnson RR, Primary diffuse large B cell lymphoma of the dural mater and cranial vault: case report and literature review. Neurosurg Focus 2006; 21: E10-3.
6. Angelo Borsarelli Carvalho Brito, Fabiano Reis, Carmino Antonio de Souza, Jose Vassallo, Carmen Silvia Passos Lima, Intracranial primary dural diffuse large B-cell lymphoma successfully treated with chemotherapy, Int J Clin Exp med 2014;7(2): 456 – 460.
7. Nayak L, Abrey LE, Iwamoto FM, Intracranial dural metastases, cancer 2009; 115: 1947 – 53.
8. Osbon, Blaser, Salziman, Katzman, Provenzale, Castillo, Hedlund, Illner, harnsberger, Cooper, Jones, Hamilton. Diagnostic Imaging Brain, 2004, p 997 –1004.
9. Safar, V, Dupuis, J, Jardin, F, et al. Early 18fluorodeoxyglucose PET Scan as a Prognostic Tool
in Diffuse Large B-Cell Lymphoma Patients Treated with An Anthracycline-Based Chemotherapy Plus Rituximab. Blood 2009; 114:45 (abstr 98).
10. Pfreundschuh M, Trümper L, Osterborg A, Pettengell R, Trneny M, Imrie K, Ma D, Gill D, Walewski J, Zinzani PL, Stahel R, Kvaloy S, Shpilberg O, Jaeger U, Hansen M, Lehtinen T, López-Guillermo A, Corrado C, Scheliga A, Milpied N, Mendila M, Rashford M, Kuhnt E, Loeffler M, MabThera International Trial Group, CHOP-like chemotherapy plus rituximab versus CHOPlike chemotherapy alone in young patients with goodprognosis diffuse large-B-cell lymphoma: a randomised controlled trial by the MabThera International Trial (MInT) Group, Lancet Oncol. 2006;7(5):379.
11. Đỗ Anh Tú (2012), Nghiên cứu đặc điểm lâm
sàng và điều trị U lympho ác tính không Hodgkin thể lan
tỏa tế bào B lớn, Trường đại học Y Hà Nội.
12. Habermann TM, Weller EA, Morrison VA, Gascoyne RD, Cassileth PA, Cohn JB, Dakhil SR, Woda B, Fisher RI, Peterson BA, Horning SJ (2006), Rituximab-CHOP versus CHOP alone or with maintenance rituximab in older patients with diffuse
large B-cell lymphoma, J Clin Oncol. 2006;24(19):3121.
1. I.S. Haldorsen, A. Espeland, E. M. Larsson, Central Nervous System Lymphoma: Characteristic Findings on Traditional and Advanced Imaging, Amerian Joural Neuroadiol 32:984 – 92, 2011.
2. Thomas P. Naidich, Mauricio Castillo, Soonmee Cha, James G. Smirnitopoulos, Imaging of the Brain (2013), Meningeal Neoplasms, p691 -727
3. Iwamoto FM, Abrey LE, Primary dural lymphomas: a review. Neurosurg Focus 2006, 21: E5 – 9.
4. Mneimneh WS, Ashraf MA, Li L, El – Kadi O, Qian J, Nazeer T, Hayner – Buchan A, Primary dural lymphoma: a novel concept of heterogeneous disease. Pathol Int 2013, 63: 68 -72.
5. GalarzaM, Gazzeri R, Elfeky HA, Johnson RR, Primary diffuse large B cell lymphoma of the dural mater and cranial vault: case report and literature review. Neurosurg Focus 2006; 21: E10-3.
6. Angelo Borsarelli Carvalho Brito, Fabiano Reis, Carmino Antonio de Souza, Jose Vassallo, Carmen Silvia Passos Lima, Intracranial primary dural diffuse large B-cell lymphoma successfully treated with chemotherapy, Int J Clin Exp med 2014;7(2): 456 – 460.
7. Nayak L, Abrey LE, Iwamoto FM, Intracranial dural metastases, cancer 2009; 115: 1947 – 53.
8. Osbon, Blaser, Salziman, Katzman, Provenzale, Castillo, Hedlund, Illner, harnsberger, Cooper, Jones, Hamilton. Diagnostic Imaging Brain, 2004, p 997 –1004.
9. Safar, V, Dupuis, J, Jardin, F, et al. Early 18fluorodeoxyglucose PET Scan as a Prognostic Tool
in Diffuse Large B-Cell Lymphoma Patients Treated with An Anthracycline-Based Chemotherapy Plus Rituximab. Blood 2009; 114:45 (abstr 98).
10. Pfreundschuh M, Trümper L, Osterborg A, Pettengell R, Trneny M, Imrie K, Ma D, Gill D, Walewski J, Zinzani PL, Stahel R, Kvaloy S, Shpilberg O, Jaeger U, Hansen M, Lehtinen T, López-Guillermo A, Corrado C, Scheliga A, Milpied N, Mendila M, Rashford M, Kuhnt E, Loeffler M, MabThera International Trial Group, CHOP-like chemotherapy plus rituximab versus CHOPlike chemotherapy alone in young patients with goodprognosis diffuse large-B-cell lymphoma: a randomised controlled trial by the MabThera International Trial (MInT) Group, Lancet Oncol. 2006;7(5):379.
11. Đỗ Anh Tú (2012), Nghiên cứu đặc điểm lâm
sàng và điều trị U lympho ác tính không Hodgkin thể lan
tỏa tế bào B lớn, Trường đại học Y Hà Nội.
12. Habermann TM, Weller EA, Morrison VA, Gascoyne RD, Cassileth PA, Cohn JB, Dakhil SR, Woda B, Fisher RI, Peterson BA, Horning SJ (2006), Rituximab-CHOP versus CHOP alone or with maintenance rituximab in older patients with diffuse
large B-cell lymphoma, J Clin Oncol. 2006;24(19):3121.